Prolonged overall survival with second on-demand autologous transplant in multiple myeloma

scientific article published on 01 June 2006

Prolonged overall survival with second on-demand autologous transplant in multiple myeloma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/AJH.20641
P698PubMed publication ID16680735

P50authorAndrea PiccinQ50214605
P2093author name stringFrancesco Rodeghiero
Eros Di Bona
Francesca Elice
Alberto Tosetto
Roberto Raimondi
Anna D'Emilio
P433issue6
P304page(s)426-431
P577publication date2006-06-01
P1433published inAmerican Journal of HematologyQ4744246
P1476titleProlonged overall survival with second on-demand autologous transplant in multiple myeloma
P478volume81

Reverse relations

cites work (P2860)
Q37677935Current multiple myeloma treatment strategies with novel agents: a European perspective
Q36612669Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma
Q37829230Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantation
Q26771331Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity
Q35569350Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities
Q34473121Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
Q38970595Management of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma
Q47196540Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT.
Q64883977Multiple Myeloma: Updates on Diagnosis and Management.
Q38261677Novel agents and new therapeutic approaches for treatment of multiple myeloma.
Q48178842Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft
Q37391117Role of autologous and allogeneic stem cell transplantation in myeloma
Q37738474Role of autologous stem cell transplantation in multiple myeloma
Q44758991Second auto-SCT for treatment of relapsed multiple myeloma
Q46745193Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial
Q41819684Stem cell transplantation for multiple myeloma
Q36556492The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
Q26851202Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
Q37949201Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.
Q64900417Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

Search more.